Results 271 to 280 of about 187,398 (301)

Ventricular arrhythmias in heart failure with reduced ejection fraction

Current Opinion in Cardiology, 2020
Purpose of review To provide a framework for approaching ventricular arrhythmias in the setting of cardiomyopathy, outline the latest evidence-based recommendations for catheter ablation and device therapy, and discuss novel treatment strategies.
Aleksandr, Voskoboinik, Joshua D, Moss
openaire   +2 more sources

Hypertension in Patients with Heart Failure with Reduced Ejection Fraction

Current Cardiology Reports, 2016
Hypertension (HTN) is a well-known health problem associated with considerable morbidity and mortality and it is an important risk factor for the development of heart failure (HF). These findings support the need for optimizing the antihypertensive strategies to prevent the progression to HF.
VOLPE, Massimo, SANTOLAMAZZA, CATERINA, TOCCI, GIULIANO   +2 more
openaire   +2 more sources

Heart Failure With Reduced Ejection Fraction

Journal of the American College of Cardiology, 2021
Clyde W. Yancy, Esther Vorovich, Sarah Chuzi   +2 more
openaire   +2 more sources

Heart Failure with Reduced Ejection Fraction

Heart Failure Clinics, 2023
Terri L. Allison, Beth Towery Davidson
openaire   +3 more sources

Heart Failure with Reduced Ejection Fraction

2022
Prashant Rao, Marwa A. Sabe
openaire   +2 more sources

Complex Energy Metabolic Changes in Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction

Canadian Journal of Cardiology, 2017
Alterations in cardiac energy metabolism contribute to the severity of heart failure. However, the energy metabolic changes that occur in heart failure are complex, and are dependent not only on the severity and type of heart failure present, but also on the coexistence of common comorbidities such as obesity and type 2 diabetes.
Kirstie A, De Jong, Gary D, Lopaschuk
openaire   +2 more sources

Developments in Heart Failure With Reduced Ejection Fraction

JAMA, 2020
Ricky D, Turgeon, Arden R, Barry
openaire   +4 more sources

Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial

Lancet, The, 2022
Sanjiv J Shah, Barry A Borlaug, Donald E Cutlip   +2 more
exaly  

Empagliflozin in Heart Failure with a Preserved Ejection Fraction

New England Journal of Medicine, 2021
Stefan D Anker, Javed Butler, Gerasimos Filippatos   +2 more
exaly  

Heart Failure with Reduced Ejection Fraction

Medical Clinics of North America
Ebrahim Barkoudah, Clyde W. Yancy
openaire   +2 more sources